Dr. Alley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2950 Cleveland Clinic Blvd
Weston, FL 33331Phone+1 954-659-5840Fax+1 954-659-5810
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1996 - 1999
- University of Kansas School of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2018 - 2025
- PA State Medical License 1997 - 2021
- NJ State Medical License 2014 - 2019
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012
- Join now to see all
Clinical Trials
- Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) Start of enrollment: 2023 Jan 10
Publications & Presentations
PubMed
- 12 citationsThe value of delayed phase enhanced imaging in malignant pleural mesothelioma.Akash M. Patel, Ian Berger, E. Paul Wileyto, Urooj Khalid, Drew A. Torigian
Journal of Thoracic Disease. 2017-08-17 - 85 citationsExtended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three YearsJoseph S. Friedberg, Charles B. Simone, Melissa Culligan, Andrew R. Barsky, Abigail Doucette
The Annals of Thoracic Surgery. 2017-03-01 - 208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM): Results from a phase 1b trialThierry Jahan, Raffit Hassan, Evan W. Alley, Hedy L. Kindler, Scott J. Antonia
Journal of Thoracic Oncology. 2016-04-01
Press Mentions
- Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for MesotheliomaSeptember 5th, 2019
- Mesothelioma Shows Promising Response to Existing Immunotherapy DrugMarch 31st, 2017
- Pembrolizumab Shows Promise in Treatment of MesotheliomaMarch 20th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: